tangotx.com (TNGX) - Full Takeover Company Value

Tango Therapeutics Corp (TNGX) - corporate logo

Tango Therapeutics (TNGX) is accelerating the search for anti-cancer agents by employing robotic CRISPR target screening to reduce manual labor. The company is currently systematically deploying its existing reserves to fund R&D, while its Enterprise Value on the GURU.Markets platform stands at 2877.49. This price chart confirms that the business value depends not on economics, but on the outcomes of clinical trials.

TNGX (Tango Therapeutics) Total Company Value history from 11/23/2025 to 10/28/2026

Tango Therapeutics - analytical breakdowns and key metrics (TNGX)

- price and consensus price forecast:
Share Price Tango Therapeutics Inc|TNGX - Analyst Consensus Forecast
- market capitalization data:
Market Capitalization Tango Therapeutics|TNGX - Real Price to Acquire Entire Company
- book capitalization data:
Equity per Share Tango Therapeutics|TNGX - Company Book Value|Market-to-Book Ratio tangotx.com|TNGX - Aggregate Company Assets
- debt and liquidity data:
Debt to Equity Ratio Tango Therapeutics|TNGX - Long-Term Debt to Capital|Short-Term Debt to Equity Ratio tangotx.com|TNGX - Company Debts|Debts to Book Value Tango Therapeutics|TNGX - Company Long-Term Debt|Company Short-Term Debt Tango Therapeutics
Fundamental valuation:Tango Therapeutics Inc (TNGX)
Original product of Tango Therapeutics, Inc.

Tango Therapeutics (TNGX) is implementing robotic small-molecule screening to accelerate the development of oncology drugs. This real acquisition price of the company sums the market capitalization and net debt, reflecting the total value of all assets. The indicator's trend allows for an assessment of the business's fundamental margin of safety net of cash. The smoothed curve filters out volatility, revealing the true volumes of institutional capital. This is critically important for liquidity analysis prior to large-scale transactions.

Competitors of Tango Therapeutics (TNGX)

Business Value ImmunityBio Inc IBRX|Enterprise Value IMCR|Janux Corp (JANX) - Full Takeover Company Value|Real Price to Acquire Entire Company Arcus Biosciences, Inc.|ZYME (zymeworks.com) - Business Value|Total Company Value IOVA (Iovance Biotherapeutics, Inc.)|Total Enterprise Value IMTX|Total Company Value Xencor Corp XNCR|Business Value Compass Therapeutics Corp (CMPX)|Replimune Group, Inc. - Enterprise Value|lyell.com - Real Price to Acquire Entire Company|IPHA (Innate Pharma) - Total Company Value|PYXS: Total Enterprise Value|cgen.com (CGEN) - Total Company Value|IOBT (IO Biotech Inc.) - Total Company Value|Total Company Value STRO (Sutro Biopharma, Inc.)|Total Enterprise Value minktherapeutics.com|HOWL: Enterprise Value|Full Takeover Company Value immixbio.com IMMX|ALXO: Real Price to Acquire Entire Company|CUE - Total Enterprise Value|Real Price to Acquire Entire Company PDS Biotechnology Corp (PDSB)|SONN - Value Adjusted for Debt and Cash|MAIA Biotechnology, Inc. - Enterprise Value|LIMN (Liminatus Pharma Inc.) - Company Buyout Price|Total Company Value LVTX|Real Price to Acquire Entire Company NXTC|Total Company Value LPTX (Leap Therapeutics, Inc.)|Real Price to Acquire Entire Company intensitytherapeutics.com INTS|Real Price to Acquire Entire Company SNSE (Sensei Biotherapeutics, Inc.)|Theriva Biologics Inc - Enterprise Value|Gritstone Bio (GRTS) - Total Company Value|KA: Business Value|Total Company Value NEXI|Total Enterprise Value Turnstone Biologics Corp.|Vaccinex - Real Price to Acquire Entire Company|Full Takeover Company Value Harpoon Therapeutics Inc (HARP)